Completed
A Phase 2 Evaluation of TRC105 In Combination With Bevacizumab in Patients With Glioblastoma
NCT01564914
- Conditions
- Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +8 more
- Locations
-
- University of Cincinnati Cincinnati, Ohio, United States
- University Hospitals of Cleveland Cleveland, Ohio, United States
- Cleveland Clinic Cleveland, Ohio, United States
- Ohio State University Columbus, Ohio, United States